Congressional Research Service IF13237
Medicare Part B Drugs Overview
Source-supplied metadata for version 1, published May 29, 2026.
Source-supplied fields
Report metadata
- Identifier
- IF13237
- Version
- 1
- Product type
- Resources
- Status
- Active
- Published
- May 29, 2026
- Source updated
- May 30, 2026, 10:07 am UTC
Authors: Laura A. Wreschnig
Source topics: Health Care Delivery, Health Care Reform, Medicare, Medicare Part B
Politically.com intentionally does not reproduce the report summary or full text. Use the official Congress.gov links above to read the product in its source context.
Structured Congress.gov references
Related federal bills
- S 1836A bill to amend title XVIII of the Social Security Act to strengthen the drug pricing reforms in the Inflation Reduction Act.119th Congress
- HR 4299To amend title XVIII of the Social Security Act to provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation.119th Congress
- S 1753A bill to require the Secretary of Health and Human Services to establish reference prices for prescription drugs for purposes of Federal health programs, and for other purposes.119th Congress
- HR 3391To require the Secretary of Health and Human Services to establish reference prices for prescription drugs for purposes of Federal health programs, and for other purposes.119th Congress